COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility

Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) raises concerns as to whether it contributes to an increased mortality. The incidence of CAPA varies widely within hospitals and countries, partly because of difficulties in obtaining a reliable diagnosis. We implemented a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lackner, Nina, Thomé, Claudius, Öfner, Dietmar, Joannidis, Michael, Mayerhöfer, Timo, Arora, Rohit, Samardzic, Eldina, Posch, Wilfried, Breitkopf, Robert, Lass-Flörl, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875712/
https://www.ncbi.nlm.nih.gov/pubmed/35205848
http://dx.doi.org/10.3390/jof8020093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875712/
https://www.ncbi.nlm.nih.gov/pubmed/35205848
http://dx.doi.org/10.3390/jof8020093

Ejemplares similares